vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and Tectonic Financial, Inc. (TECTP). Click either name above to swap in a different company.

Tectonic Financial, Inc. is the larger business by last-quarter revenue ($23.0M vs $16.1M, roughly 1.4× Fortress Biotech, Inc.). Tectonic Financial, Inc. runs the higher net margin — 23.8% vs -24.5%, a 48.4% gap on every dollar of revenue. On growth, Tectonic Financial, Inc. posted the faster year-over-year revenue change (17.9% vs 6.3%). Over the past eight quarters, Tectonic Financial, Inc.'s revenue compounded faster (270.5% CAGR vs 11.0%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

Tectonic Financial, Inc. is a US-based diversified financial services provider. It offers core services including wealth management, investment banking, capital markets advisory, and tailored financial solutions. Its key client segments cover high-net-worth individuals, institutional investors, and small to mid-sized enterprises across North America.

FBIO vs TECTP — Head-to-Head

Bigger by revenue
TECTP
TECTP
1.4× larger
TECTP
$23.0M
$16.1M
FBIO
Growing faster (revenue YoY)
TECTP
TECTP
+11.6% gap
TECTP
17.9%
6.3%
FBIO
Higher net margin
TECTP
TECTP
48.4% more per $
TECTP
23.8%
-24.5%
FBIO
Faster 2-yr revenue CAGR
TECTP
TECTP
Annualised
TECTP
270.5%
11.0%
FBIO

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
FBIO
FBIO
TECTP
TECTP
Revenue
$16.1M
$23.0M
Net Profit
$-3.9M
$5.5M
Gross Margin
66.1%
Operating Margin
-28.8%
30.6%
Net Margin
-24.5%
23.8%
Revenue YoY
6.3%
17.9%
Net Profit YoY
41.8%
15.9%
EPS (diluted)
$-0.15
$0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
TECTP
TECTP
Q4 25
$16.1M
Q3 25
$17.6M
$23.0M
Q2 25
$16.4M
$21.6M
Q1 25
$13.1M
$21.8M
Q4 24
$15.1M
$21.4M
Q3 24
$14.6M
$19.5M
Q2 24
$14.9M
$18.6M
Q1 24
$13.0M
$17.6M
Net Profit
FBIO
FBIO
TECTP
TECTP
Q4 25
$-3.9M
Q3 25
$5.8M
$5.5M
Q2 25
$15.5M
$4.3M
Q1 25
$-10.6M
$4.5M
Q4 24
$-6.8M
$3.0M
Q3 24
$-12.9M
$4.7M
Q2 24
$-10.9M
$3.1M
Q1 24
$-15.4M
$3.1M
Gross Margin
FBIO
FBIO
TECTP
TECTP
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
FBIO
FBIO
TECTP
TECTP
Q4 25
-28.8%
Q3 25
-38.6%
30.6%
Q2 25
-222.2%
25.9%
Q1 25
-169.9%
26.0%
Q4 24
-158.3%
22.1%
Q3 24
-151.0%
29.1%
Q2 24
-186.5%
21.5%
Q1 24
-280.6%
22.2%
Net Margin
FBIO
FBIO
TECTP
TECTP
Q4 25
-24.5%
Q3 25
33.2%
23.8%
Q2 25
94.4%
19.8%
Q1 25
-80.6%
20.4%
Q4 24
-44.7%
14.0%
Q3 24
-88.0%
24.2%
Q2 24
-73.5%
16.9%
Q1 24
-118.3%
17.4%
EPS (diluted)
FBIO
FBIO
TECTP
TECTP
Q4 25
$-0.15
Q3 25
$0.11
$0.73
Q2 25
$0.45
$0.55
Q1 25
$-0.48
$0.57
Q4 24
$-0.16
$0.35
Q3 24
$-0.76
$0.58
Q2 24
$-0.73
$0.38
Q1 24
$-1.04
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
TECTP
TECTP
Cash + ST InvestmentsLiquidity on hand
$79.4M
Total DebtLower is stronger
$52.4M
Stockholders' EquityBook value
$49.9M
$119.2M
Total Assets
$185.5M
$1.1B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
TECTP
TECTP
Q4 25
$79.4M
Q3 25
$86.2M
Q2 25
$74.4M
Q1 25
$91.3M
Q4 24
$57.3M
Q3 24
$58.9M
Q2 24
$76.2M
Q1 24
$83.8M
Total Debt
FBIO
FBIO
TECTP
TECTP
Q4 25
$52.4M
Q3 25
$47.8M
Q2 25
$50.0M
Q1 25
$56.4M
Q4 24
$58.0M
Q3 24
$52.5M
Q2 24
$67.0M
Q1 24
$61.4M
Stockholders' Equity
FBIO
FBIO
TECTP
TECTP
Q4 25
$49.9M
Q3 25
$55.9M
$119.2M
Q2 25
$43.9M
$114.6M
Q1 25
$22.3M
$111.3M
Q4 24
$22.7M
$113.4M
Q3 24
$21.2M
$112.8M
Q2 24
$17.9M
$110.4M
Q1 24
$23.0M
$108.5M
Total Assets
FBIO
FBIO
TECTP
TECTP
Q4 25
$185.5M
Q3 25
$181.4M
$1.1B
Q2 25
$159.9M
$997.0M
Q1 25
$178.1M
$910.5M
Q4 24
$144.2M
$863.4M
Q3 24
$127.1M
$847.5M
Q2 24
$145.7M
$777.1M
Q1 24
$164.6M
$777.6M
Debt / Equity
FBIO
FBIO
TECTP
TECTP
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
Q3 24
2.48×
Q2 24
3.75×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
TECTP
TECTP
Operating Cash FlowLast quarter
$-12.5M
$-17.3M
Free Cash FlowOCF − Capex
$-17.3M
FCF MarginFCF / Revenue
-74.9%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-3.14×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
TECTP
TECTP
Q4 25
$-12.5M
Q3 25
$-6.1M
$-17.3M
Q2 25
$-27.6M
$-32.5M
Q1 25
$-19.6M
$-35.6M
Q4 24
$-12.9M
$-86.6M
Q3 24
$-20.1M
$-22.5M
Q2 24
$-21.8M
$-30.7M
Q1 24
$-25.4M
$-3.2M
Free Cash Flow
FBIO
FBIO
TECTP
TECTP
Q4 25
Q3 25
$-17.3M
Q2 25
Q1 25
$-35.6M
Q4 24
$-86.8M
Q3 24
$-22.5M
Q2 24
$-30.7M
Q1 24
$-3.3M
FCF Margin
FBIO
FBIO
TECTP
TECTP
Q4 25
Q3 25
-74.9%
Q2 25
Q1 25
-163.2%
Q4 24
-406.5%
Q3 24
-115.0%
Q2 24
-165.5%
Q1 24
-18.8%
Capex Intensity
FBIO
FBIO
TECTP
TECTP
Q4 25
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
1.0%
Q3 24
0.0%
0.1%
Q2 24
0.3%
Q1 24
0.9%
Cash Conversion
FBIO
FBIO
TECTP
TECTP
Q4 25
Q3 25
-1.04×
-3.14×
Q2 25
-1.78×
-7.61×
Q1 25
-8.00×
Q4 24
-28.99×
Q3 24
-4.74×
Q2 24
-9.76×
Q1 24
-1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons